A window of opportunity
Millions of people will die unnecessarily unless a massive effort is made to tackle the worsening global cancer epidemic. But the investment in cancer control that is so desperately needed, particularly in low – and [more]
2008
Paolo Casali: the man with the method
Paolo Casali specialises in sarcoma, a rare’ cancer with at least 50 subgroups.Good practice, he believes, starts with a deep knowledge of the disease in front of you. This, in turn, requires a rigorous approach [more]
Controversial issues in managing locally advanced head and neck cancers
Great strides have beenmade inmanaging patients with locally advanced squamous cell cancer of the head and neck over the past 20 years. Novel approaches using chemoradiation (CRT) have improved disease control and quality of life. [more]
When is it OK to randomise cancer patients to placebo?
No-one wants to see progress in cancer research more than the patients themselves. But how do we deal with potential conflicts of interest when testing new drugs involves giving placebos to people dying of cancer? [more]
A reverence for life in turbulent times
A young child in war time Germany, Stephan Tanneberger grew up to take a lead in oncology in the communist East, which achieved some of the lowest cancer mortality rates in Europe. His career was [more]
If nothing is done…
The more we know about cancer, the harder it becomes to present a coherent and accurate picture of the nature of the threat and what canand what cannot be achieved through changing lifestyles, screening and [more]
Bringing truths about cancer to new audiences
When it comes to challenging taboos and giving a voice to ordinary people with extraordinary stories, film can be immensely powerful, as was shown at the first ever Reel Lives: Cancer Chronicles Film Festival, held [more]
Concomitant difluoromethylornithine/ sulindac chemoprevention of colorectal adenomas: a major clinical advance
Combining two drugs, i.e. difluoromethylornithine and sulindac, at low doses has been shown, for the first time, to provide both great efficacy and great safety for clinical colon cancer prevention. Download full article
The ROC n’ role of the multiplex assay for early detection of ovarian cancer
The sensitivity and specificity of CA125 for early detection of ovarian cancer is improved when analysed in combination with novel biomarkers, although further validation studies are required to confirm the clinical utility of the multiplex [more]
N E W S R O U N D
Selected reports edited by Janet Fricker Download full article
A diet of hopes and half-truths
The media often hype the benefits of superfoods’ to protect against or even cure cancer. But keeping weight down and taking exercise are known to offer far greater protection than any individual food or nutrient [more]
ECCOESMO: a powerful partnership
Bridging the bench-to-bedside gap and promoting multidisciplinarity are pivotal to advancing research and improving patient treatment and care. The implementation and measurable outcomes of both ideals in everyday practice generally translate into increased dialogue and [more]
Nadia Harbeck: breaking with convention
Gynaecologists don’t win top awards at ASCO. German oncologists don’t make it on the international stage. Women who want large families can’t expect to be leaders in their field. Nadia Harbeck’s high-flying career and relaxed [more]